11/14/2025
We are proud to have been a clinical site for this significant study and deeply grateful to the dedicated patients who participated. Their participation has been crucial to advancing medical research and offers hope for improved treatment options in the future.
Source:
https://multiplesclerosisnewstoday.com/news-posts/2025/11/13/ms-drug-fenebrutinib-shows-unprecedented-results-trials/